Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Antibiotics specialty page provides antibiotics-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

ANTIBIOTICS NEWS - Page 1

Diagnosis and Management of Gram-Negative Nosocomial Infections
Patient and institutional history, as well as the individual niches of the new antibiotics, need to be considered when selecting a treatment for gram-negative infections.
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Iclaprim Found to be Effective and Safe Treatment for Acute Bacterial Skin and Skin Structure Infections
Pooled analyses of 2 phase 3 trials have conclusively established the safety and effectiveness of iclaprim compared to vancomycin in the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Pooled IGNITE 1 and 4 Results Reinforce the Efficacy and Safety of Eravacycline for Complicated Intra-abdominal Infections
The pooled results have hammered home the promise of eravacycline for the treatment of patients with cIAIs who are colonized by drug-resistant bacteria.
First 'Triple Threat' Strain of <em>Klebsiella pneumoniae</em> Found in the United States
An extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.
Colistin-Resistant <em>E coli</em> Found in Almost All Residents of Rural Vietnam Village
Sixty-nine out of the 70 colistin-resistant isolates had either mcr-1 and/or mcr-3 genes.
Fluoroquinolones As Alternate Therapy Option for Bloodstream Infections in Some Patients
Empiric use of fluoroquinolones looks to be an alternate option for the treatment of gram-negative bloodstream infections when risk factors for antimicrobial resistance are not present.
FEATURED
Big advances in treatment can